Literature DB >> 20617828

Pressurized liquid extraction as an alternative process to obtain antiviral agents from the edible microalga Chlorella vulgaris.

Susana Santoyo1, Merichel Plaza, Laura Jaime, Elena Ibañez, Guillermo Reglero, Francisco J Señorans.   

Abstract

The antiviral properties of pressurized liquid extracts (PLE) (acetone, ethanol, and water) obtained from the edible microalga Chlorella vulgaris were evaluated against herpes simplex virus type 1 (HSV-1). None of the extracts tested showed extracellular direct virucidal activity against the virus, although a pretreatment of Vero cells with 75 microg/mL of water and ethanol extracts before virus addition inhibited 70% of the virus infection. Moreover, water and ethanol extracts were able to significantly inhibit the in vitro virus replication, showing IC(50%) values of 61.05 and 80.23 microg/mL respectively. To identify the type of compounds responsible for the antiviral activity found in the water extract, the polysaccharide fraction was isolated. This activity was found to correlate with polysaccharides, because the polysaccharide-rich fraction (46% concentrated) showed higher antiviral activity than the complete water extract. A concentration of 75 microg/mL of this fraction inhibited 90% virus infection when added as a pretreatment and showed an IC(50%) value of 33.93 microg/mL for intracellular virus replication. GC-MS characterization of the ethanol extract showed that the antiviral activity of this extract could be partially related with the presence of phytol, although other compounds could be involved in this activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20617828     DOI: 10.1021/jf100369h

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  7 in total

1.  Viral inhibitors derived from macroalgae, microalgae, and cyanobacteria: A review of antiviral potential throughout pathogenesis.

Authors:  Daman Reynolds; Michael Huesemann; Scott Edmundson; Amy Sims; Brett Hurst; Sherry Cady; Nathan Beirne; Jacob Freeman; Adam Berger; Song Gao
Journal:  Algal Res       Date:  2021-05-18       Impact factor: 4.401

2.  Preliminary characterization of the structure and immunostimulatory and anti-aging properties of the polysaccharide fraction of Haematococcus pluvialis.

Authors:  Xiaojuan Liu; Miao Zhang; Han Liu; Aimei Zhou; Yong Cao; Xin Liu
Journal:  RSC Adv       Date:  2018-03-02       Impact factor: 4.036

Review 3.  Antimicrobial Compounds from Eukaryotic Microalgae against Human Pathogens and Diseases in Aquaculture.

Authors:  Charlotte Falaise; Cyrille François; Marie-Agnès Travers; Benjamin Morga; Joël Haure; Réjean Tremblay; François Turcotte; Pamela Pasetto; Romain Gastineau; Yann Hardivillier; Vincent Leignel; Jean-Luc Mouget
Journal:  Mar Drugs       Date:  2016-09-02       Impact factor: 5.118

Review 4.  Broad Spectrum Algae Compounds Against Viruses.

Authors:  Jacqueline Graff Reis; Rafael Dorighello Cadamuro; Ariadne Cristiane Cabral; Izabella Thaís da Silva; David Rodríguez-Lázaro; Gislaine Fongaro
Journal:  Front Microbiol       Date:  2022-01-14       Impact factor: 5.640

5.  Inhibitory properties of crude microalgal extracts on the in vitro replication of cyprinid herpesvirus 3.

Authors:  Stefanie Fritzsche; Patrik Blenk; Jürgen Christian; Kathrin Castiglione; Anna Maria Becker
Journal:  Sci Rep       Date:  2021-11-30       Impact factor: 4.379

6.  Matrix solid-phase dispersion as a greener alternative to obtain bioactive extracts from Haematococcus pluvialis. Characterization by UHPLC-QToF.

Authors:  Aly Castillo; Simón Pereira; Ana Otero; Sarah Fiol; Carmen Garcia-Jares; Marta Lores
Journal:  RSC Adv       Date:  2020-07-28       Impact factor: 3.361

7.  Chlorella sorokiniana-Induced Activation and Maturation of Human Monocyte-Derived Dendritic Cells through NF-κB and PI3K/MAPK Pathways.

Authors:  Nien-Tzu Chou; Chieh-Fang Cheng; Hsin-Chieh Wu; Chin-Pen Lai; Li-Tsen Lin; I-Horng Pan; Ching-Huai Ko
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-25       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.